Avant Healthcare is a medical marketing communications agency that focuses on the education and engagement of healthcare professionals. For the past 20 years, Avant Healthcare has partnered with pharmaceutical, biotechnology, diagnostic, and medical device companies, including the support of multibillion dollar brands, from prelaunch through product expiration. Whether working from a promotional or nonpromotional standpoint, we increase our clients’ effectiveness by combining best-in-class strategy, curriculum development, technology, and creative design to deliver high-impact, high-quality medical education and measurable results.
With more than 180 staff members, Avant Healthcare is a certified diversity supplier (Women’s Business Enterprise National Council) based in Carmel, Indiana, with remote teams in the Los Angeles and Chicago areas. Key services include Medical Storytelling (creative content development that is compelling and memorable); KOL Strategy and Management (matching the best experts to fulfill business needs); and Integrated Customer Experiences (positively reinforcing key messages at every customer touch point: before, during, and after content delivery).
- Company Resources
Video Conference Case Study
Avant Healthcare was approached with a challenge: How to "wow" the field sales force by developing new programming that is easy, effective, and cost-efficient. Take a look at this case study infographic to see the results.
TL Engagement and the Sunshine Act
Thought leader engagement has the potential to be impacted by provisions within the Physician Payment Sunshine Act (PPSA). This white paper explores ways that brand teams can build strong thought leader relationships while remaining compliant with these new regulations.
Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.
- US pharma market value projected to be $550 billion in five years
- Biosimilar uptake will require companies to tell a trustworthy backstory
- Lawmakers propose allowing pharma companies to share some off-label information
- Apple's ResearchKit: Five Guidelines for Pharma
- Everyday Health buys rare-disease agency Cambridge BioMarketing